Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response.

about

Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response.

Item

http://www.wikidata.org/entity/Q38634561

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Differential Effects of Antire ...... nd Integrated Stress Response.

@en

type

Item

label

Differential Effects of Antire ...... nd Integrated Stress Response.

@en

prefLabel

Differential Effects of Antire ...... nd Integrated Stress Response.

@en

P1476

Differential Effects of Antire ...... and Integrated Stress Response

@en

P2093

Anna L Stern

http://www.w3.org/2001/XMLSchema#string

Jiean Li

http://www.w3.org/2001/XMLSchema#string

Kelly L Jordan-Sciutto

http://www.w3.org/2001/XMLSchema#string

Nina Panvelker

http://www.w3.org/2001/XMLSchema#string

Rebecca N Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological brake-release of mRNA translation enhances cognitive memory

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment

Q27009249

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).

Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation.

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects.

P2888

s11481-017-9761-6

P304

64-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11481-017-9761-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cagla Akay

Jenna Harowitz

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091404889

http://www.w3.org/2001/XMLSchema#string

P698

28861811

http://www.w3.org/2001/XMLSchema#string

P932

5821494

http://www.w3.org/2001/XMLSchema#string